1. Asymmetric dimethylarginine (ADMA) mediates the effect of miRNA-762 on all-cause mortality in patients with coronary artery disease. (August 2022) Authors: Jarzebska, N.; Tselmin, S.; Kleber, M.E.; Maerz, W.; Jin, H.; Bornstein, S.; Mangoni, A.; Weiss, N.; Rodionov, R. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Increased risk of acute stroke among patients with severe COVID‐19: a multicenter study and meta‐analysis. (16th October 2020) Authors: Siepmann, T.; Sedghi, A.; Simon, E.; Winzer, S.; Barlinn, J.; de With, K.; Mirow, L.; Wolz, M.; Gruenewald, T.; Schroettner, P.; von Bonin, S.; Pallesen, L.‐P.; Rosengarten, B.; Schubert, J.; Lohmann, T.; Machetanz, J.; Spieth, P.; Koch, T.; Bornstein, S.; Reichmann, H. Journal: European journal of neurology Issue: Volume 28:Number 1(2021) Page Start: 238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗